Abstract

Purpose

The identification and referral of patients in need of palliative care should be improved. The French society for palliative support and care recommended to use the PALLIA‐10 questionnaire and its score greater than 3 to refer patients to palliative care. We explored the use of the PALLIA‐10 questionnaire and its related score in a population of advanced cancer patients.

Methods

This prospective multicentric study is to be conducted in authorized French comprehensive cancer centers on hospitalized patients on a given day. We aimed to use the PALLIA‐10 score to determine the proportion of palliative patients with a score >3. Main secondary endpoints were to determine the proportion of patients already managed by palliative care teams at the study date or referred to palliative care in six following months, the prevalence of patients with a score greater than 5, and the overall survival using the predefined thresholds of 3 and 5.

Results

In 2015, eighteen French cancer centers enrolled 840 patients, including 687 (82%) palliative patients. 479 (69.5%) patients had a score >3, 230 (33.5%) had a score >5, 216 (31.4%) patients were already followed‐up by a palliative care team, 152 patients were finally referred to PC in the six subsequent months.

The PALLIA‐10 score appeared as a reliable predictive (adjusted ORRef≤3: 1.9 [1.17‐3.16] and 3.59 [2.18‐5.91]) and prognostic (adjusted HRRef≤3 = 1.58 [95%CI 1.20‐2.08] and 2.18 [95%CI 1.63‐2.92]) factor for patients scored 4‐5 and >5, respectively.

Conclusion

The PALLIA‐10 questionnaire is an easy‐to‐use tool to refer cancer inpatients to palliative care in current practice. However a score greater than 5 using the PALLIA‐10 questionnaire would be more appropriate for advanced cancer patients hospitalized in comprehensive cancer center.

Details

Title
PALLIA ‐10, a screening tool to identify patients needing palliative care referral in comprehensive cancer centers: A prospective multicentric study ( PREPA ‐10)
Author
Molin, Yann 1 ; Gallay, Caroline 2 ; Gautier, Julien 3 ; Audrey Lardy‐Cleaud 3 ; Mayet, Romaine 3 ; Marie‐Christine Grach 4 ; Guesdon, Gérard 5 ; Capodano, Géraldine 6 ; Dubroeucq, Olivier 7 ; Bouleuc, Carole 8 ; Bremaud, Nathalie 9 ; Fogliarini, Anne 10 ; Henry, Aline 11 ; Nathalie Caunes‐Hilary 12 ; Villet, Stéphanie 13 ; Villatte, Christine 14 ; Frasie, Véronique 15 ; Triolaire, Valérie 16 ; Barbarot, Véronique 17 ; Jean‐Marie Commer 18 ; Hutin, Agnès 19 ; Chvetzoff, Gisèle 1   VIAFID ORCID Logo 

 Léon Bérard cancer center, Lyon, France 
 Cancer Institute of Montpellier, Montpellier, France 
 Direction of Clinical Research and Innovation, Lyon, France 
 François Baclesse Cancer Centre, Caen, France 
 Bergonié Cancer Institute, Bordeaux, France 
 Paoli‐Calmettes Institute, Marseille, France 
 Jean Godinot Cancer Institute, Reims, France 
 Curie Institute, Paris, France 
 George‐François Leclerc Cancer Center, Dijon, France 
10  Antoine Lacassagne Cancer Center, Nice, France 
11  Cancer Institute of Lorraine – Alexis Vautrin, Nancy, France 
12  IUC Toulouse Oncopole, Toulouse, France 
13  Oscar Lambret Cancer Center, Lille, France 
14  Jean Perrin Cancer Center, Clermont Ferrand, France 
15  Paul Strauss Cancer Center, Strasbourg, France 
16  Curie Institute, Saint Cloud, France 
17  West Cancer Institute, Saint Herblain, René Gauducheau Center, Nantes, France 
18  Paul Papin Cancer Center, Angers, France 
19  Eugène Marquis Cancer Center, Rennes, France 
Pages
2950-2961
Section
CLINICAL CANCER RESEARCH
Publication year
2019
Publication date
Jun 2019
Publisher
John Wiley & Sons, Inc.
e-ISSN
20457634
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2242883391
Copyright
Copyright John Wiley & Sons, Inc. Jun 2019